12 December 2024 - Today, the US FDA’s Center for Drug Evaluation and Research (CDER) announced the new CDER Center for Real World Evidence Innovation (CCRI) which aims to coordinate, advance, and promote the use of real world data and real world evidence in regulatory decision-making across the CDER.
The goal of CCRI will be to advance, coordinate, and promote consistency across real world data/real world evidence related initiatives in CDER, including related uses of emerging technologies in both internal and external FDA activities.